The shift from fee-for-service to value-based care continues to expand each year. The majority of healthcare stakeholders think about payers, providers, and patients when they think about the shift to value-based care. However, medical device companies can have an important role to play in improving patient outcomes and lowering costs. With the right data, analytic strategy, and program governance, forward-leaning companies can make an impact.

Learn about Medtronic’s value-based healthcare strategy as a means to create benefits for providers, payers, and most importantly patients.

Attendees will learn: 

  • Why medical device companies should have a value-based strategy
  • Key steps needed to embark on a strategy which includes partnerships, governance, and data and analytics
  • Data required to measure and track patient experience and outcomes
  • Real world example of how Medtronic has put this into practice

Featured Speakers

Christian Howell

VP Value-Based Healthcare Partnerships, Americas Region

Christian is responsible for the development of strategic partnerships with leading health systems and the execution of Medtronic’s value based-health care strategy. In this role, he establishes and manages key relationships with various stakeholders throughout health care systems, developing innovative ways to leverage Medtronic's full portfolio of products, services, and business programs to support a value-based health care environment.

Lynda Rowe

Sr. Advisor, Value-Based Markets

Ms. Lynda Rowe is Senior Advisor for Value-Based Markets at InterSystems acting as a subject matter expert around the shift to value-based payment models. For the past two decades, Ms. Rowe has held senior-level positions in health information technology. Her experience spans work for payers, health systems, start-ups, vendors and the federal government.


Register now for this webinar